Thrombosis and infections associated with PICC in onco-hematological patients, what is their relevance?

Purpose Peripherally inserted central venous catheters (PICC) in the onco-hematological patients may be associated with thrombosis or infections that may have short- to medium-term repercussions. Material and methods Single-centre retrospective analysis of a prospectively collected cohort. Primary o...

Full description

Saved in:

Bibliographic Details
Published in:	Clinical & translational oncology Vol. 26; no. 12; pp. 3226 - 3235
Main Authors:	Sánchez Cánovas, Manuel, García Torralba, Esmeralda, Blaya Boluda, Noel, Sánchez Saura, Ana, Puche Palao, Gabriel, Sánchez Fuentes, Ana, Martínez Montesinos, Lorena, Poveda Ganga, Carmen, García Tomas, Lucía, Bayona Jiménez, Josefa, Cos Zapata, Ángeles, Muñoz Jurado, Carmen María, Pina Mingorance, Inmaculada, Caravaca Hernández, María Amor, Vicente García, Vicente, Ayala de la Peña, Francisco
Format:	Journal Article
Language:	English
Published:	Cham Springer International Publishing 12-06-2024
Subjects:	Medicine Medicine & Public Health Oncology Research Article PICC-associated thrombosis PICC-associated infections Hematological patients Peripherally inserted central venous catheters Oncological patients
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Purpose Peripherally inserted central venous catheters (PICC) in the onco-hematological patients may be associated with thrombosis or infections that may have short- to medium-term repercussions. Material and methods Single-centre retrospective analysis of a prospectively collected cohort. Primary objective was to establish the PICC-thrombosis and infections incidence. Secondary objectives were to analyze profile of patients suffering from these complications and variables associated with an increased likelihood of developing these events. Results 549 patients were recruited. 58.5% ( n = 321) were oncology patients and 41.5% ( n = 228) hematology patients. The incidence of PICC-associated thrombosis was 3.5% ( n = 19). Thrombosis was associated with progression of the underlying malignant pathology in 10.6% ( n = 2) of cases. No association was found between clinical variables analysed and development of thrombosis. Incidence of PICC-associated infections was 7.65% ( n = 42). In the 30 days prior to PICC infection, 57.1% ( n = 24) had a febrile syndrome of another focus, 73.8% ( n = 11) had been hospitalized, 49.5% ( n = 25) had a neutrophil count of 0–500 cells/mm3 and 47.6% ( n = 20) had an episode of neutropenic fever. Variables significantly associated with the development of infection were hematological patients, high-flow PICC, 3-lm PICC or PICC insertion because of administration of vesicant therapy. Conclusions Incidence of PICC-associated thrombosis is low and apparently less prognostically aggressive than other forms of thrombosis associated with cancer, without identify predictive factors. Infection was more prevalent and the identification of risk factors in our series could facilitate its prevention.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	1699-3055 1699-3055
DOI:	10.1007/s12094-024-03548-8